Published in J Biol Chem on September 28, 2006
Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol (2009) 2.44
Pharmacology of ginsenosides: a literature review. Chin Med (2010) 1.94
Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med (2007) 1.36
A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment. PLoS One (2012) 1.20
American ginseng preferentially suppresses STAT/iNOS signaling in activated macrophages. J Ethnopharmacol (2009) 1.03
Why is Research on Herbal Medicinal Products Important and How Can We Improve Its Quality? J Tradit Complement Med (2014) 1.02
Panax ginseng extract rich in ginsenoside protopanaxatriol offers combinatorial effects in nitric oxide production via multiple signaling pathways. Springerplus (2013) 1.01
Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells. Br J Pharmacol (2009) 0.97
Ginsenoside Rg1 promotes endothelial progenitor cell migration and proliferation. Acta Pharmacol Sin (2009) 0.95
Up-regulation of Heme Oxygenase-1 by Korean Red Ginseng Water Extract as a Cytoprotective Effect in Human Endothelial Cells. J Ginseng Res (2011) 0.93
MicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells Angiogenesis. J Cell Physiol (2015) 0.89
Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: ginsenoside Rg1 partially supports myelopoiesis. PLoS One (2012) 0.89
Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats. J Zhejiang Univ Sci B (2015) 0.85
Korean red ginseng inhibits arginase and contributes to endotheliumdependent vasorelaxation through endothelial nitric oxide synthase coupling. J Ginseng Res (2013) 0.83
The protective effects of ginsenoside Rg1 against hypertension target-organ damage in spontaneously hypertensive rats. BMC Complement Altern Med (2012) 0.82
Effects of ginsenoside Rb₁ on skin changes. J Biomed Biotechnol (2012) 0.79
Protective effects of ginsenoside Rg1 on intestinal ischemia/reperfusion injury-induced oxidative stress and apoptosis via activation of the Wnt/β-catenin pathway. Sci Rep (2016) 0.78
Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors. Br J Pharmacol (2015) 0.77
Notoginsenoside R1 reduces blood pressure in spontaneously hypertensive rats through a long non-coding RNA AK094457. Int J Clin Exp Pathol (2015) 0.76
Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng. J Neuroimmune Pharmacol (2011) 0.76
Ginsenoside Rg1 protects starving H9c2 cells by dissociation of Bcl-2-Beclin1 complex. BMC Complement Altern Med (2016) 0.75
In vitro evaluation of Panax notoginseng Rg1 released from collagen/chitosan-gelatin microsphere scaffolds for angiogenesis. Biomed Eng Online (2013) 0.75
Ginsenoside Rg1 improves bone marrow haematopoietic activity via extramedullary haematopoiesis of the spleen. J Cell Mol Med (2015) 0.75
Identification of natural products with neuronal and metabolic benefits through autophagy induction. Autophagy (2016) 0.75
MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells. Oncotarget (2017) 0.75
Korean Red Ginseng extract induces angiogenesis through activation of glucocorticoid receptor. J Ginseng Res (2016) 0.75
Modulating angiogenesis: the yin and the yang in ginseng. Circulation (2004) 1.86
Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol (2008) 1.60
The angiosuppressive effects of 20(R)- ginsenoside Rg3. Biochem Pharmacol (2006) 1.47
p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res (2008) 1.38
Gonadotropins and ovarian cancer. Endocr Rev (2007) 1.35
Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci (2006) 1.28
Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9. Cancer Res (2006) 1.23
Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology (2006) 1.20
Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett (2006) 1.15
Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology (2006) 1.12
The anti-angiogenic effect of sinomenine. Angiogenesis (2005) 1.08
A simplified method for quantifying cell migration/wound healing in 96-well plates. J Biomol Screen (2010) 1.08
Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor. FEBS Lett (2007) 1.07
Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis. Angiogenesis (2011) 1.02
Synergistic effects of epidermal growth factor and hepatocyte growth factor on human ovarian cancer cell invasion and migration: role of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Endocrinology (2007) 1.00
Gonadotropins regulate N-cadherin-mediated human ovarian surface epithelial cell survival at both post-translational and transcriptional levels through a cyclic AMP/protein kinase A pathway. J Biol Chem (2005) 0.98
Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. Exp Cell Res (2008) 0.97
Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells. Br J Pharmacol (2009) 0.97
Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues. FEBS J (2008) 0.96
Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK. FEBS Lett (2008) 0.96
Liquid chromatography/mass spectrometric analysis of rat samples for in vivo metabolism and pharmacokinetic studies of ginsenoside Rh2. Rapid Commun Mass Spectrom (2005) 0.93
In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.91
Effect of sinomenine on gene expression of the IL-1 beta-activated human synovial sarcoma. Life Sci (2006) 0.91
Effects of Si-Jun-Zi decoction polysaccharides on cell migration and gene expression in wounded rat intestinal epithelial cells. Br J Nutr (2005) 0.90
Exploiting p70 S6 kinase as a target for ovarian cancer. Expert Opin Ther Targets (2012) 0.90
HGF/MET signaling in ovarian cancer. Curr Mol Med (2008) 0.89
MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2. Biochem Pharmacol (2013) 0.88
Inhibition of shear-induced platelet aggregation in rat by tetramethylpyrazine and salvianolic acid B. Clin Hemorheol Microcirc (2004) 0.87
Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1. Cardiovasc Res (2010) 0.87
Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro. Angiogenesis (2005) 0.87
Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells. Endocrinology (2010) 0.86
Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the beta-catenin/T-cell factor signaling pathway. Mol Endocrinol (2006) 0.86
Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies. Gynecol Oncol (2005) 0.86
Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry. Mutat Res (2008) 0.84
Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell line. Differentiation (2004) 0.84
Nur77: a potential therapeutic target in cancer. Expert Opin Ther Targets (2012) 0.84
Cytoprotective effect of 20S-Rg3 on benzo[a]pyrene-induced DNA damage. Drug Metab Dispos (2011) 0.83
The melanogenesis-inhibitory effect and the percutaneous formulation of ginsenoside Rb1. AAPS PharmSciTech (2014) 0.81
Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor. Biochem Biophys Res Commun (2005) 0.81
Liquid chromatography/mass spectrometry for metabonomics investigation of the biochemical effects induced by aristolochic acid in rats: the use of information-dependent acquisition for biomarker identification. Rapid Commun Mass Spectrom (2008) 0.79
Role of p38 MAPKs in hypericin photodynamic therapy-induced apoptosis of nasopharyngeal carcinoma cells. Photochem Photobiol (2009) 0.79
p70 S6 kinase and actin dynamics: A perspective. Spermatogenesis (2012) 0.79
Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion. Endocrine (2007) 0.79
Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion. Mol Ther (2012) 0.78
Assessing phylogenetic relationships of Lycium samples using RAPD and entropy theory. Acta Pharmacol Sin (2005) 0.78
CpG/CpNpG motifs in the coding region are preferred sites for mutagenesis in the breast cancer susceptibility genes. FEBS Lett (2007) 0.78
Human female reproductive tract epithelial cell culture. Methods Mol Biol (2013) 0.77
Detection of single nucleotide polymorphisms in hepatitis B virus precore/basal core promoter region by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem (2007) 0.76
Characterization of the DNA adducts induced by aristolochic acids in oligonucleotides by electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom (2008) 0.76
Bisindigotin, a TCDD antagonist from the Chinese medicinal herb Isatis indigotica. J Nat Prod (2005) 0.76
An experimental model of ovarian carcinoma: more than just genetics. Cell Cycle (2010) 0.75
Effects of supercoiling on the sequence-specific photo-modification of DNA by a vanadium(V)-peroxo complex. J Inorg Biochem (2005) 0.75
Synthesis and Biological Evaluations of Cytotoxic and Antiangiogenic Triterpenoids-Jacaranone Conjugates. Med Chem (2016) 0.75
Substrates with patterned topography reveal metastasis of human cancer cells. Biomed Mater (2017) 0.75
Simultaneous detection of precore/basal core promoter mutations in hepatitis B virus using arrayed primer extension. Mol Diagn Ther (2006) 0.75